Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
4
pubmed:dateCreated
2010-3-29
pubmed:abstractText
The EGFR [epidermal growth factor receptor (erythroblastic leukemia viral (v-erb-b) oncogene homolog, avian)] gene is known to harbor genomic alterations in advanced lung cancer involving gene amplification and kinase mutations that predict the clinical response to EGFR-targeted inhibitors. Methods for detecting such molecular changes in lung cancer tumors are desirable.
pubmed:grant
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Apr
pubmed:issn
1530-8561
pubmed:author
pubmed:issnType
Electronic
pubmed:volume
56
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
623-32
pubmed:meshHeading
pubmed-meshheading:20207772-Adult, pubmed-meshheading:20207772-Aged, pubmed-meshheading:20207772-Aged, 80 and over, pubmed-meshheading:20207772-Alleles, pubmed-meshheading:20207772-DNA, Neoplasm, pubmed-meshheading:20207772-DNA Mutational Analysis, pubmed-meshheading:20207772-Disease Progression, pubmed-meshheading:20207772-Female, pubmed-meshheading:20207772-Genome, Human, pubmed-meshheading:20207772-Genotype, pubmed-meshheading:20207772-Humans, pubmed-meshheading:20207772-Lung Neoplasms, pubmed-meshheading:20207772-Male, pubmed-meshheading:20207772-Middle Aged, pubmed-meshheading:20207772-Mutation, pubmed-meshheading:20207772-Neoplasm Staging, pubmed-meshheading:20207772-Polymerase Chain Reaction, pubmed-meshheading:20207772-Predictive Value of Tests, pubmed-meshheading:20207772-Receptor, Epidermal Growth Factor, pubmed-meshheading:20207772-Tumor Cells, Cultured
pubmed:year
2010
pubmed:articleTitle
Quantifying EGFR alterations in the lung cancer genome with nanofluidic digital PCR arrays.
pubmed:affiliation
Fluidigm Corporation, South San Francisco, CA, USA.
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't, Research Support, N.I.H., Extramural